Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab for Bone Loss in Women With Anorexia Nervosa
NCT04779216Phase 3Completed
- Start
- Sep 2021
- Primary completion
- Oct 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of romosozumab in osteoporosis. Started Sep 2021; status: completed.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04779216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779216.